Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 October, 2014 23:50 IST
News
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS | 19 Nov, 2012, 09.43AM
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*


Live News
McDonalds Q3 earnings drop - 21-Oct-2014 18:47
Angel Broking recommends Accumulate on HDFC Bank - 21-Oct-2014 18:35
Manpower third quarter profit jumps - 21-Oct-2014 18:31
Computer Task Group Q3 earnings drop - 21-Oct-2014 18:30
Lockheed Martin Q3 profit climbs - 21-Oct-2014 18:23
Waters Corp third quarter profit climbs - 21-Oct-2014 18:21
Ministry of Steel to set up Steel Research & Technology Mission of India - 21-Oct-2014 18:06
Need to strengthen Indo-French cooperation in agro-processing sector: Harsimrat Kaur Badal - 21-Oct-2014 18:00
FIIs hike stake in Exide Industries - 21-Oct-2014 17:51
Synovus Financial Q3 profit rises marginally - 21-Oct-2014 17:47
Customers Bancorp Q3 profit surges - 21-Oct-2014 17:44
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   w5j8pb into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer